JR, H., W, L., D, W., H, Z., W, C., JB, B., . . . SM, P. (2019). Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 25(8), 2523. https://doi.org/10.1158/1078-0432.CCR-18-3094
Chicago Style (17th ed.) CitationJR, Heyza, Lei W, Watza D, Zhang H, Chen W, Back JB, Schwartz AG, Bepler G, and Patrick SM. "Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25, no. 8 (2019): 2523. https://doi.org/10.1158/1078-0432.CCR-18-3094.
MLA (9th ed.) CitationJR, Heyza, et al. "Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 25, no. 8, 2019, p. 2523, https://doi.org/10.1158/1078-0432.CCR-18-3094.
